临床研究
动脉注入自体CD133+细胞对糖尿病外周动脉疾病
|
|
CD133+ |
控制 |
|
|
VEGF
(pg / mL) |
治疗前 |
69.65±4.43 |
71.68±5.99 |
0.166 |
| 1 w |
79.01±7.75 |
74.65±6.74 |
0.034 |
| 2 w |
82.45±4.74 |
74.07±8.00 |
0.000 |
| 4 w |
78.61±5.04 |
72.88±6.64 |
0.001 |
|
il - 6
(pg / mL) |
治疗前 |
124.53±19.94 |
114.24±25.79 |
0.109 |
| 1 w |
98.66±17.85 |
111.16±21.60 |
0.026 |
| 2 w |
71.00±25.19 |
96.25±16.98 |
0.000 |
| 4 w |
81.22±20.22 |
101.16±22.27 |
0.001 |
|
|
w:一周。
|
